Equillium, Inc. Files 8-K on Corporate Changes
Ticker: EQ · Form: 8-K · Filed: Oct 6, 2025 · CIK: 1746466
| Field | Detail |
|---|---|
| Company | Equillium, INC. (EQ) |
| Form Type | 8-K |
| Filed Date | Oct 6, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001, $363,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, personnel-changes, filing-update
Related Tickers: EQ
TL;DR
Equillium filed an 8-K detailing director/officer changes and accountant updates. Big shakeup.
AI Summary
Equillium, Inc. filed an 8-K on October 6, 2025, reporting changes related to its certifying accountant, departure/election of directors, appointment of officers, and compensatory arrangements. The filing also covers other events and financial statements/exhibits as of September 30, 2025.
Why It Matters
This filing indicates significant corporate governance and personnel updates within Equillium, Inc., which could impact strategic direction and operational management.
Risk Assessment
Risk Level: medium — Changes in directors, officers, and certifying accountants can signal underlying issues or strategic shifts that may affect the company's future performance.
Key Players & Entities
- Equillium, Inc. (company) — Registrant
- 20251006 (date) — Filing Date
- 20250930 (date) — Period of Report
- 2223 Avenida de la Playa, Suite 105, La Jolla, California 92037 (address) — Principal Executive Offices
FAQ
What specific changes were made regarding Equillium, Inc.'s certifying accountant?
The filing indicates 'Changes in Registrant's Certifying Accountant' as an item of information, but the specific details of the change are not provided in this summary.
Who are the new directors or officers appointed, and who departed?
The filing lists 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' as an item of information, but the names of individuals involved are not detailed in this summary.
What are the key compensatory arrangements for certain officers mentioned?
The filing notes 'Compensatory Arrangements of Certain Officers' as an item of information, but the specifics of these arrangements are not elaborated upon in this summary.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated September 30, 2025.
What is Equillium, Inc.'s principal business sector?
Equillium, Inc. is in the Pharmaceutical Preparations sector, with SIC code 2834.
Filing Stats: 1,605 words · 6 min read · ~5 pages · Grade level 12.4 · Accepted 2025-10-06 16:05:10
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share EQ Nasdaq Capital Market
- $363,000 — the Company a technical service fee of $363,000. In lieu of Biocon paying the technical
Filing Documents
- d930780d8k.htm (8-K) — 37KB
- d930780dex161.htm (EX-16.1) — 4KB
- g930780g1004052852628.jpg (GRAPHIC) — 2KB
- g930780g1004052852847.jpg (GRAPHIC) — 2KB
- 0001193125-25-231860.txt ( ) — 163KB
- eq-20250930.xsd (EX-101.SCH) — 3KB
- eq-20250930_lab.xml (EX-101.LAB) — 18KB
- eq-20250930_pre.xml (EX-101.PRE) — 11KB
- d930780d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 16.1 Letter from KPMG LLP to the SEC dated October 6, 2025. 104 Cover Page Interactive Data File (embedded with the Inline XBRL document). SIGNATURE Pursuant to the requirement of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EQUILLIUM, INC. Date: October 6, 2025 By: /s/ Bruce D. Steel Name: Bruce D. Steel Title: Chief Executive Officer